Cancer Biostatistics Training Program

The Center for Cancer Biostatistics is the home to the Cancer Biostatistics Training Program, a program funded by the National Cancer Institute (NCI) to support the training of PhD students.

This program supports the training activities of students to learn about biostatistical methods relevant to cancer and to gain experience undertaking cancer research. The training is achieved through coursework, seminars, journals clubs, working groups and research meetings.

At any one time, typically 6 - 12 students are engaged in biostatistical training related to cancer research. The students will either be graduate student assistants working on specific projects or trainees supported by the Cancer Biostatistics Training Program grant.

The primary biostatistical training facility will be the Department of Biostatistics in the School of Public Health at the University of Michigan. The department is top ranked in the United States, with many internationally regarded faculty and a vibrant research and teaching program. It is one of six departments in an outstanding School of Public Health, with close links to the Statistics Department and the Bioinformatics Program at the University of Michigan. It is located in close proximity to the University of Michigan Medical Center and the Rogel Cancer Center.

The Department of Biostatistics is a leader in the development and application of statistical methods in the biomedical sciences. It is an expanding department with over 40 faculty and more than 180 graduate students. The faculty includes leading researchers in the areas of survival analysis, missing data, longitudinal and correlated data analysis and statistical genetics. It has extensive collaboration with The University of Michigan Medical Center in many areas, including cancer, diabetes, kidney disease, imaging, genomics and Alzheimer’s.

The Rogel Cancer Center at The University of Michigan is a very successful cancer center with over 70 million dollars in grant funding. The University of Michigan is consistently ranked very highly in cancer research funding from the NCI. It has an extensive research program, including clinical research in many disease sites (prostate, breast, head and neck, skin cancer leukemia, etc.). It has successful programs in basic science, behavioral science, epidemiology and genomics. It has very active research programs in imaging, genomics and proteomics.